Primus In News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
15-03-2025
Nilaya Varma, CEO & Co-Founder, Primus Partners, and Vivek Tandon, Vice President, Primus Partners, share their view on the expansion of Indian pharmaceutical companies in the US through strategic acquisitions. They highlight Sun Pharma’s $355 million acquisition of Checkpoint Therapeutics as a key move to bolster its oncology and immunotherapy portfolio.
Explore Related Insights
- Will 90 bps hike in repo rates in 2 MPC meetings help tame 95-month high inflation?
- New GST return filing rules to help streamline process, increase transparency, better traceability by govt, say experts
- Strategic Digital Evolution: Google India and Primus Partners Spearhead conversation on Responsible AI and its applicability
- PM GatiShakti now open to public: Goyal
